Immunotherapy and Immune Infiltration in Patients with Clear Cell Renal Cell Carcinoma: A Comprehensive Analysis

Figure 6

(a) The results of GSVA based on the HALLMARK enrichment analysis; (b) the results of GSVA based on HALLMARK enrichment analysis; (c) the GO BP enrichment analysis based on genes involved in the MEred module; (d) the GO CC enrichment analysis based on genes involved in the MEred module; (e) the GO MF enrichment analysis based on genes involved in the MEred module.

(a)

(b)

(c)

(d)

(e)